Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,516
Closed -$207K 374
2024
Q1
$207K Buy
+5,516
New +$197K ﹤0.01% 371
2015
Q1
Sell
-13,706
Closed -$363K 337
2014
Q4
$363K Buy
13,706
+280
+2% +$7.18K 0.01% 284
2014
Q3
$326K Sell
13,426
-981
-7% -$23K 0.01% 289
2014
Q2
$375K Buy
14,407
+62
+0.4% +$1.58K 0.01% 266
2014
Q1
$343K Hold
14,345
0.01% 279
2013
Q4
$280K Sell
14,345
-3,645
-20% -$73.3K 0.01% 283
2013
Q3
$381K Sell
17,990
-877
-5% -$19.2K 0.01% 277
2013
Q2
$415K Buy
+18,867
New +$458K 0.01% 248

Other funds holding EXC

Welch & Forbes's EXC Position: Q2 2024 in Review

Welch & Forbes sold out of Exelon (EXC) in Q2 2024, closing a stake of 5,516 shares — an estimated $207K sold.

Welch & Forbes first reported a position in EXC in Q2 2013 and held it in 8 quarters. The position peaked at $415K in Q2 2013. 989 funds tracked by Wall St. Rank hold EXC as of Q2 2024.

  • Welch & Forbes reported no remaining Exelon position as of Q2 2024 after selling out during the quarter.
  • Welch & Forbes sold 5,516 Exelon shares in Q2 2024, an estimated $207K.
  • Welch & Forbes first reported a position in Exelon in Q2 2013 and held it in 8 quarters.
  • Welch & Forbes's Exelon position peaked at $415K in Q2 2013.
  • 989 funds tracked by Wall St. Rank held Exelon as of Q2 2024.

Based on Welch & Forbes's 13F filing for Q2 2024, filed 2 Aug 2024.